verubulin: Clinical Trials

6 trials of verubulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Unknown 1
Phase 24Completed 3, Unknown 1

Follow verubulin: new trials by email Literature Review of verubulin trials Research Report on verubulin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme
Verubulin, Temozolomide & Radiation Therapy - Glioblastoma Multiforme
Phase 2CompletedMyrexis Inc.52010-12-012012-04-11
Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
Azixa - Glioblastoma Multiforme
Phase 2CompletedMyrexis Inc.562009-04-012011-10-14
Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma
MPC-6827 + Temozolomide - Metastatic Melanoma
Phase 1 / Phase 2CompletedMyrexis Inc.222008-03-012010-08-23
Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
MPC-6827 + Carboplatin - Glioblastoma Multiforme
Phase 1 / Phase 2UnknownMyrexis Inc.302008-03-012011-03-25
Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases
MPC-6827 - Brain Neoplasms
Phase 1CompletedMyrexis Inc.182005-12-012008-02-13
Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors
MPC-6827 - Refractory Solid Tumors
Phase 1CompletedMyrexis Inc.482005-03-012008-02-13

Conditions studied

Brain Neoplasms (3)  ·  Glioblastoma (3)  ·  Neoplasm Metastasis (2)  ·  Recurrence (2)  ·  Melanoma (1)

Sponsors

Myrexis Inc. (6)

Countries

United States (6)

Top investigators

Andrew Beelen, MD (2)  ·  Andrew P. Beelen, MD (2)  ·  Margaret Yu, MD (2)  ·  Lawrence Recht, MD (1)